Remedy · drug
Dapagliflozin
Also: Farxiga
A SGLT2 inhibitor antidiabetic drug.
Evidence by condition
Each grade reflects the research for Dapagliflozin and that condition specifically.
No graded conditions recorded yet.
Dapagliflozin is a SGLT2 inhibitor antidiabetic drug. This is a reference stub — its uses and interactions are not yet curated here.
Source: U.S. FDA drug labeling via openFDA (public domain).